[New AMM: Nivolumab as an adjuvant for oesophageal and gastroesophageal junction cancer].

Bull Cancer

Centre Léon-Bérard, département d'oncologie médicale, 28, rue Laënnec, 69008 Lyon, France.

Published: April 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2021.11.018DOI Listing

Publication Analysis

Top Keywords

[new amm
4
amm nivolumab
4
nivolumab adjuvant
4
adjuvant oesophageal
4
oesophageal gastroesophageal
4
gastroesophageal junction
4
junction cancer]
4
[new
1
nivolumab
1
adjuvant
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!